ANTICOV: Clinical trial for COVID-19 in low-r
[ad_1] KINSHASA / NAIROBI / GENEVA – 10 February 2022 – The ANTICOV platform clinical trial has started the recruitment of participants to test a new promising drug combination, fluoxetine and budesonide, as an early treatment for people affected with mild-to-moderate COVID-19. The ANTICOV trial, currently conducted in […]
ANTICOV: Clinical trial for COVID-19 in low-r Read More »


















